These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32142293)

  • 1. Modulation of Microenvironmental Acidity: A Strategy to Mitigate Salt Disproportionation in Drug Product Environment.
    Koranne S; Lalge R; Suryanarayanan R
    Mol Pharm; 2020 Apr; 17(4):1324-1334. PubMed ID: 32142293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of Spatial Heterogeneity of Salt Disproportionation in Tablets by Synchrotron X-ray Diffractometry.
    Koranne S; Govindarajan R; Suryanarayanan R
    Mol Pharm; 2017 Apr; 14(4):1133-1144. PubMed ID: 28195490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Excipients on Salt Disproportionation during Dissolution: A Novel Application of In Situ Raman Imaging.
    Abouselo A; Rance GA; Tres F; Taylor LS; Kwokal A; Renou L; Scurr DJ; Burley JC; Aylott JW
    Mol Pharm; 2021 Sep; 18(9):3247-3259. PubMed ID: 34399050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the Influence of Excipients on the Stability of Levothyroxine Sodium Pentahydrate.
    Kaur N; Suryanarayanan R
    Mol Pharm; 2021 Jul; 18(7):2683-2693. PubMed ID: 34061524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystalline solid dispersion-a strategy to slowdown salt disproportionation in solid state formulations during storage and wet granulation.
    Nie H; Xu W; Taylor LS; Marsac PJ; Byrn SR
    Int J Pharm; 2017 Jan; 517(1-2):203-215. PubMed ID: 27979765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulating weakly basic HCl salts: relative ability of common excipients to induce disproportionation and the unique deleterious effects of magnesium stearate.
    John CT; Xu W; Lupton LK; Harmon PA
    Pharm Res; 2013 Jun; 30(6):1628-41. PubMed ID: 23512680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative Salt Selection and Formulation Optimization: Perspectives of Disproportionation and Microenvironmental pH Modulation.
    Mohan S; Li Y; Chu K; De La Paz L; Sperger D; Shi B; Foti C; Rucker V; Lai C
    Mol Pharm; 2024 May; 21(5):2590-2605. PubMed ID: 38656981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Metallic Stearates on Disproportionation of Hydrochloride Salts of Weak Bases in Solid-State Formulations.
    Nie H; Xu W; Ren J; Taylor LS; Marsac PJ; John CT; Byrn SR
    Mol Pharm; 2016 Oct; 13(10):3541-3552. PubMed ID: 27542728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of excipient properties, water activity, and water content on the disproportionation of a pharmaceutical salt.
    Patel MA; Luthra S; Shamblin SL; Arora KK; Krzyzaniak JF; Taylor LS
    Int J Pharm; 2018 Jul; 546(1-2):226-234. PubMed ID: 29772284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in Transitioning Cocrystals from Bench to Bedside: Dissociation in Prototype Drug Product Environment.
    Koranne S; Sahoo A; Krzyzaniak JF; Luthra S; Arora KK; Suryanarayanan R
    Mol Pharm; 2018 Aug; 15(8):3297-3307. PubMed ID: 29947519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disproportionation of Pharmaceutical Salts: pH
    Avdeef A
    Mol Pharm; 2021 Jul; 18(7):2724-2743. PubMed ID: 34142831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying Disproportionation in Pharmaceutical Formulations with
    Hirsh DA; Su Y; Nie H; Xu W; Stueber D; Variankaval N; Schurko RW
    Mol Pharm; 2018 Sep; 15(9):4038-4048. PubMed ID: 30016112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disproportionation of the calcium salt of atorvastatin in the presence of acidic excipients.
    Christensen NP; Rantanen J; Cornett C; Taylor LS
    Eur J Pharm Biopharm; 2012 Oct; 82(2):410-6. PubMed ID: 22824098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting and Quantifying Microscale Chemical Reactions in Pharmaceutical Tablets by Stimulated Raman Scattering Microscopy.
    Figueroa B; Nguyen T; Sotthivirat S; Xu W; Rhodes T; Lamm MS; Smith RL; John CT; Su Y; Fu D
    Anal Chem; 2019 May; 91(10):6894-6901. PubMed ID: 31009215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface acidity and solid-state compatibility of excipients with an acid-sensitive API: case study of atorvastatin calcium.
    Govindarajan R; Landis M; Hancock B; Gatlin LA; Suryanarayanan R; Shalaev EY
    AAPS PharmSciTech; 2015 Apr; 16(2):354-63. PubMed ID: 25319055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salt Disproportionation in the Solid State: Role of Solubility and Counterion Volatility.
    Thakral NK; Behme RJ; Aburub A; Peterson JA; Woods TA; Diseroad BA; Suryanarayanan R; Stephenson GA
    Mol Pharm; 2016 Dec; 13(12):4141-4151. PubMed ID: 27766882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salt disproportionation: A material science perspective.
    Thakral NK; Kelly RC
    Int J Pharm; 2017 Mar; 520(1-2):228-240. PubMed ID: 28163222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Lattice Disorder in Water-Mediated Dissociation of Pharmaceutical Cocrystal Systems.
    Kaur N; Duggirala NK; Thakral S; Suryanarayanan R
    Mol Pharm; 2019 Jul; 16(7):3167-3177. PubMed ID: 31117742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA; Ji Q; Joshi YM; Serajuddin AT
    Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
    Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
    Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.